Author:
Wang Feng,Feng Xiaochen,Guo Xiao,Xu Lei,Xie Liangxu,Chang Shan
Abstract
The application of deep learning in the field of drug discovery brings the development and expansion of molecular generative models along with new challenges in this field. One of challenges in de novo molecular generation is how to produce new reasonable molecules with desired pharmacological, physical, and chemical properties. To improve the similarity between the generated molecule and the starting molecule, we propose a new molecule generation model by embedding Long Short-Term Memory (LSTM) and Attention mechanism in CycleGAN architecture, LA-CycleGAN. The network layer of the generator in CycleGAN is fused head and tail to improve the similarity of the generated structure. The embedded LSTM and Attention mechanism can overcome long-term dependency problems in treating the normally used SMILES input. From our quantitative evaluation, we present that LA-CycleGAN expands the chemical space of the molecules and improves the ability of structure conversion. The generated molecules are highly similar to the starting compound structures while obtaining expected molecular properties during cycle generative adversarial network learning, which comprehensively improves the performance of the generative model.
Funder
Natural Science Foundation of Jiangsu Province
Subject
Genetics(clinical),Genetics,Molecular Medicine
Reference40 articles.
1. Artificial intelligence in drug discovery and development.;Agrawal;J. Pharmacovigil,2018
2. Exploring the GDB-13 chemical space using deep generative models.;Arús-Pous;J. Cheminform.,2019
3. ChemGAN challenge for drug discovery: can AI reproduce natural chemical diversity?;Benhenda;arXiv,2017
4. Automatic chemical design using a data-driven continuous representation of molecules.;Gómez-Bombarelli;ACS Central Sci.,2018
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献